4-aminoquinoline has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abbadi, BL; Basso, LA; Bizarro, CV; Borges Martinelli, LK; Borsoi, AF; Corso Minotto, AC; da Silva Dadda, A; da Silva Rodrigues Junior, V; de Matos Czeczot, A; Denise de Moura Sperotto, N; Dias de Oliveira, S; Duarte, LS; Galina, L; Leyser, M; Macchi Hopf, FS; Machado, P; Madeira Silva, RB; Muniz, MN; Neves, CE; Paz, JD; Perelló, MA; Pissinate, K; Rambo, RS; Ramos, AS; Roth, CD | 1 |
| Belouzard, S; Cocquerel, L; Danneels, A; Dubuisson, J; Fénéant, L; Foquet, L; Lavie, M; Lemasson, M; Melnyk, P; Mesalam, AA; Meuleman, P; Rosenberg, AR; Rouillé, Y; Séron, K; Vausselin, T; Wychowski, C | 1 |
| Abramo, C; Alves, MJ; Carmo, AM; Coimbra, ES; da Silva, AD; de Souza, NB; Fontes, AP; Lagatta, DC | 1 |
3 other study(ies) available for 4-aminoquinoline and Disease Models, Animal
| Article | Year |
|---|---|
Novel 4-aminoquinolines: Synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase, antitubercular activity, SAR, and preclinical evaluation.
Topics: Aminoquinolines; Animals; Antitubercular Agents; Disease Models, Animal; Enzyme Inhibitors; Mice; Mycobacterium tuberculosis; NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases; Tuberculosis | 2023 |
Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
Topics: Aminoquinolines; Animals; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Mice; Mice, SCID; Models, Molecular; Molecular Structure; Mutation, Missense; Reverse Genetics; Treatment Outcome; Viral Envelope Proteins; Virus Internalization | 2016 |
4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents.
Topics: Aminoquinolines; Animals; Antimalarials; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Macrophages, Peritoneal; Malaria; Mice; Molecular Structure; Organoplatinum Compounds; Plasmodium berghei | 2011 |